Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

BHST vs NXRT vs GFAI vs SIGA vs XTLB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BHST
BioHarvest Sciences Inc. Common Stock

Agricultural Inputs

Basic MaterialsNASDAQ • CA
Market Cap$95M
5Y Perf.-11.2%
NXRT
NexPoint Residential Trust, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$758M
5Y Perf.-28.3%
GFAI
Guardforce AI Co., Limited

Security & Protection Services

IndustrialsNASDAQ • SG
Market Cap$11M
5Y Perf.-52.5%
SIGA
SIGA Technologies, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$337M
5Y Perf.-34.9%
XTLB
XTL Biopharmaceuticals Ltd.

Biotechnology

HealthcareNASDAQ • IL
Market Cap$358K
5Y Perf.-63.7%

BHST vs NXRT vs GFAI vs SIGA vs XTLB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BHST logoBHST
NXRT logoNXRT
GFAI logoGFAI
SIGA logoSIGA
XTLB logoXTLB
IndustryAgricultural InputsREIT - ResidentialSecurity & Protection ServicesDrug Manufacturers - Specialty & GenericBiotechnology
Market Cap$95M$758M$11M$337M$358K
Revenue (TTM)$33M$252M$72M$95M$451K
Net Income (TTM)$-12M$-32M$-24M$23M$-1M
Gross Margin59.2%91.1%15.1%68.6%26.4%
Operating Margin-18.8%11.5%-27.4%25.1%-481.6%
Forward P/E2.8x
Total Debt$14M$1.56B$3M$795K$138K
Cash & Equiv.$2M$14M$22M$154.97T$371K

BHST vs NXRT vs GFAI vs SIGA vs XTLBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BHST
NXRT
GFAI
SIGA
XTLB
StockOct 24May 26Return
BioHarvest Sciences… (BHST)10088.8-11.2%
NexPoint Residentia… (NXRT)10071.7-28.3%
Guardforce AI Co., … (GFAI)10047.5-52.5%
SIGA Technologies, … (SIGA)10065.1-34.9%
XTL Biopharmaceutic… (XTLB)10036.3-63.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: BHST vs NXRT vs GFAI vs SIGA vs XTLB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SIGA leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. NexPoint Residential Trust, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. BHST also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
BHST
BioHarvest Sciences Inc. Common Stock
The Growth Play

BHST ranks third and is worth considering specifically for growth exposure.

  • Rev growth 98.8%, EPS growth 14.0%, 3Y rev CAGR 128.8%
  • 98.8% revenue growth vs XTLB's -173.2%
Best for: growth exposure
NXRT
NexPoint Residential Trust, Inc.
The Real Estate Income Play

NXRT is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 12 yrs, beta 0.62, yield 7.1%
  • Beta 0.62 vs GFAI's 2.31
  • 7.1% yield, 12-year raise streak, vs SIGA's 12.8%, (3 stocks pay no dividend)
Best for: income & stability
GFAI
Guardforce AI Co., Limited
The Industrials Pick

GFAI lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: industrials exposure
SIGA
SIGA Technologies, Inc.
The Long-Run Compounder

SIGA carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 7.2% 10Y total return vs NXRT's 211.0%
  • Lower volatility, beta 1.15, Low D/E 0.0%, current ratio 11.83x
  • Beta 1.15, yield 12.8%, current ratio 11.83x
  • Better valuation composite
Best for: long-term compounding and sleep-well-at-night
XTLB
XTL Biopharmaceuticals Ltd.
The Healthcare Pick

Among these 5 stocks, XTLB doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthBHST logoBHST98.8% revenue growth vs XTLB's -173.2%
ValueSIGA logoSIGABetter valuation composite
Quality / MarginsSIGA logoSIGA24.6% margin vs XTLB's -227.7%
Stability / SafetyNXRT logoNXRTBeta 0.62 vs GFAI's 2.31
DividendsNXRT logoNXRT7.1% yield, 12-year raise streak, vs SIGA's 12.8%, (3 stocks pay no dividend)
Momentum (1Y)SIGA logoSIGA+0.6% vs GFAI's -52.0%
Efficiency (ROA)SIGA logoSIGA0.0% ROA vs GFAI's -50.2%, ROIC 0.0% vs -41.6%

BHST vs NXRT vs GFAI vs SIGA vs XTLB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BHSTBioHarvest Sciences Inc. Common Stock
FY 2024
Total
50.3%$25M
Products
49.7%$25M
NXRTNexPoint Residential Trust, Inc.

Segment breakdown not available.

GFAIGuardforce AI Co., Limited

Segment breakdown not available.

SIGASIGA Technologies, Inc.
FY 2025
Product Sales and Supportive Services
93.1%$88M
Research and Development
6.9%$7M
XTLBXTL Biopharmaceuticals Ltd.

Segment breakdown not available.

BHST vs NXRT vs GFAI vs SIGA vs XTLB — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSIGALAGGINGXTLB

Income & Cash Flow (Last 12 Months)

SIGA leads this category, winning 3 of 6 comparable metrics.

NXRT is the larger business by revenue, generating $252M annually — 557.9x XTLB's $451,000. SIGA is the more profitable business, keeping 24.6% of every revenue dollar as net income compared to XTLB's -2.3%. On growth, BHST holds the edge at +38.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBHST logoBHSTBioHarvest Scienc…NXRT logoNXRTNexPoint Resident…GFAI logoGFAIGuardforce AI Co.…SIGA logoSIGASIGA Technologies…XTLB logoXTLBXTL Biopharmaceut…
RevenueTrailing 12 months$33M$252M$72M$95M$451,000
EBITDAEarnings before interest/tax-$5M$125M-$12M$24M-$1M
Net IncomeAfter-tax profit-$12M-$32M-$24M$23M-$1M
Free Cash FlowCash after capex-$10M$79M-$6M$49M$0
Gross MarginGross profit ÷ Revenue+59.2%+91.1%+15.1%+68.6%+26.4%
Operating MarginEBIT ÷ Revenue-18.8%+11.5%-27.4%+25.1%-4.8%
Net MarginNet income ÷ Revenue-36.3%-12.7%-32.9%+24.6%-2.3%
FCF MarginFCF ÷ Revenue-30.8%+31.2%-8.8%+51.5%-3.7%
Rev. Growth (YoY)Latest quarter vs prior year+38.7%+0.5%+3.6%-95.3%
EPS Growth (YoY)Latest quarter vs prior year+12.5%0.0%+38.9%-111.8%+20.0%
SIGA leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

SIGA leads this category, winning 3 of 5 comparable metrics.
MetricBHST logoBHSTBioHarvest Scienc…NXRT logoNXRTNexPoint Resident…GFAI logoGFAIGuardforce AI Co.…SIGA logoSIGASIGA Technologies…XTLB logoXTLBXTL Biopharmaceut…
Market CapShares × price$95M$758M$11M$337M$357,581
Enterprise ValueMkt cap + debt − cash$107M$2.3B-$8M-$154.97T$124,581
Trailing P/EPrice ÷ TTM EPS-5.25x-23.69x-0.94x14.24x-0.34x
Forward P/EPrice ÷ next-FY EPS est.2.76x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple18.61x-6387033.21x
Price / SalesMarket cap ÷ Revenue3.78x3.01x0.30x3.56x0.79x
Price / BookPrice ÷ Book value/share51.14x2.52x0.17x0.00x0.07x
Price / FCFMarket cap ÷ FCF9.06x6.91x
SIGA leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

SIGA leads this category, winning 4 of 9 comparable metrics.

SIGA delivers a 0.0% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-12 for BHST. SIGA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BHST's 10.39x. On the Piotroski fundamental quality scale (0–9), BHST scores 6/9 vs XTLB's 3/9, reflecting solid financial health.

MetricBHST logoBHSTBioHarvest Scienc…NXRT logoNXRTNexPoint Resident…GFAI logoGFAIGuardforce AI Co.…SIGA logoSIGASIGA Technologies…XTLB logoXTLBXTL Biopharmaceut…
ROE (TTM)Return on equity-12.0%-10.1%-69.7%0.0%-25.5%
ROA (TTM)Return on assets-41.5%-1.7%-50.2%0.0%-17.7%
ROICReturn on invested capital-70.4%+1.1%-41.6%+0.0%-54.1%
ROCEReturn on capital employed-65.1%+1.5%-19.1%0.0%-50.7%
Piotroski ScoreFundamental quality 0–964653
Debt / EquityFinancial leverage10.39x5.18x0.08x0.00x0.03x
Net DebtTotal debt minus cash$11M$1.5B-$19M-$154.97T-$233,000
Cash & Equiv.Liquid assets$2M$14M$22M$154.97T$371,000
Total DebtShort + long-term debt$14M$1.6B$3M$795,169$138,000
Interest CoverageEBIT ÷ Interest expense-1.10x0.47x-167.24x-13.31x
SIGA leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SIGA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in SIGA five years ago would be worth $10,096 today (with dividends reinvested), compared to $49 for GFAI. Over the past 12 months, SIGA leads with a +0.6% total return vs GFAI's -52.0%. The 3-year compound annual growth rate (CAGR) favors SIGA at 6.8% vs GFAI's -59.7% — a key indicator of consistent wealth creation.

MetricBHST logoBHSTBioHarvest Scienc…NXRT logoNXRTNexPoint Resident…GFAI logoGFAIGuardforce AI Co.…SIGA logoSIGASIGA Technologies…XTLB logoXTLBXTL Biopharmaceut…
YTD ReturnYear-to-date-19.4%+2.7%-22.2%-15.5%+35.4%
1-Year ReturnPast 12 months-35.9%-15.5%-52.0%+0.6%-43.6%
3-Year ReturnCumulative with dividends-16.0%-15.4%-93.5%+21.7%-33.9%
5-Year ReturnCumulative with dividends-16.0%-21.7%-99.5%+1.0%-76.3%
10-Year ReturnCumulative with dividends-16.0%+211.0%-99.5%+722.2%-84.5%
CAGR (3Y)Annualised 3-year return-5.6%-5.4%-59.7%+6.8%-12.9%
SIGA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

NXRT leads this category, winning 2 of 2 comparable metrics.

NXRT is the less volatile stock with a 0.62 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXRT currently trades 77.9% from its 52-week high vs XTLB's 31.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBHST logoBHSTBioHarvest Scienc…NXRT logoNXRTNexPoint Resident…GFAI logoGFAIGuardforce AI Co.…SIGA logoSIGASIGA Technologies…XTLB logoXTLBXTL Biopharmaceut…
Beta (5Y)Sensitivity to S&P 5001.05x0.62x2.31x1.15x1.71x
52-Week HighHighest price in past year$12.80$38.30$1.50$9.62$10.28
52-Week LowLowest price in past year$4.10$23.79$0.38$4.29$1.05
% of 52W HighCurrent price vs 52-week peak+32.8%+77.9%+33.2%+48.9%+31.6%
RSI (14)Momentum oscillator 0–10043.169.251.244.067.4
Avg Volume (50D)Average daily shares traded23K219K405K683K2.4M
NXRT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — NXRT and SIGA each lead in 1 of 2 comparable metrics.

Analyst consensus: BHST as "Buy", NXRT as "Hold", SIGA as "Buy". Consensus price targets imply 138.1% upside for BHST (target: $10) vs -9.5% for NXRT (target: $27). For income investors, SIGA offers the higher dividend yield at 12.81% vs NXRT's 7.06%.

MetricBHST logoBHSTBioHarvest Scienc…NXRT logoNXRTNexPoint Resident…GFAI logoGFAIGuardforce AI Co.…SIGA logoSIGASIGA Technologies…XTLB logoXTLBXTL Biopharmaceut…
Analyst RatingConsensus buy/hold/sellBuyHoldBuy
Price TargetConsensus 12-month target$10.00$27.00
# AnalystsCovering analysts1101
Dividend YieldAnnual dividend ÷ price+7.1%+12.8%
Dividend StreakConsecutive years of raises124
Dividend / ShareAnnual DPS$2.11$0.60
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.0%0.0%0.0%0.0%
Evenly matched — NXRT and SIGA each lead in 1 of 2 comparable metrics.
Key Takeaway

SIGA leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). NXRT leads in 1 (Risk & Volatility). 1 tied.

Best OverallSIGA Technologies, Inc. (SIGA)Leads 4 of 6 categories
Loading custom metrics...

BHST vs NXRT vs GFAI vs SIGA vs XTLB: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is BHST or NXRT or GFAI or SIGA or XTLB a better buy right now?

For growth investors, BioHarvest Sciences Inc.

Common Stock (BHST) is the stronger pick with 98. 8% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate BioHarvest Sciences Inc. Common Stock (BHST) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — BHST or NXRT or GFAI or SIGA or XTLB?

Over the past 5 years, SIGA Technologies, Inc.

(SIGA) delivered a total return of +1. 0%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — BHST or NXRT or GFAI or SIGA or XTLB?

By beta (market sensitivity over 5 years), NexPoint Residential Trust, Inc.

(NXRT) is the lower-risk stock at 0. 62β versus Guardforce AI Co. , Limited's 2. 31β — meaning GFAI is approximately 271% more volatile than NXRT relative to the S&P 500. On balance sheet safety, SIGA Technologies, Inc. (SIGA) carries a lower debt/equity ratio of 0% versus 10% for BioHarvest Sciences Inc. Common Stock — giving it more financial flexibility in a downturn.

04

Which is growing faster — BHST or NXRT or GFAI or SIGA or XTLB?

By revenue growth (latest reported year), BioHarvest Sciences Inc.

Common Stock (BHST) is pulling ahead at 98. 8% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: Guardforce AI Co. , Limited grew EPS 88. 3% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, BHST leads at 128. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — BHST or NXRT or GFAI or SIGA or XTLB?

SIGA Technologies, Inc.

(SIGA) is the more profitable company, earning 24. 6% net margin versus -227. 7% for XTL Biopharmaceuticals Ltd. — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -481. 6% for XTLB. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is BHST or NXRT or GFAI or SIGA or XTLB more undervalued right now?

Analyst consensus price targets imply the most upside for BHST: 138.

1% to $10. 00.

07

Which pays a better dividend — BHST or NXRT or GFAI or SIGA or XTLB?

In this comparison, SIGA (12.

8% yield), NXRT (7. 1% yield) pay a dividend. BHST, GFAI, XTLB do not pay a meaningful dividend and should not be held primarily for income.

08

Is BHST or NXRT or GFAI or SIGA or XTLB better for a retirement portfolio?

For long-horizon retirement investors, NexPoint Residential Trust, Inc.

(NXRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 62), 7. 1% yield, +211. 0% 10Y return). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NXRT: +211. 0%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between BHST and NXRT and GFAI and SIGA and XTLB?

These companies operate in different sectors (BHST (Basic Materials) and NXRT (Real Estate) and GFAI (Industrials) and SIGA (Healthcare) and XTLB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BHST is a small-cap high-growth stock; NXRT is a small-cap income-oriented stock; GFAI is a small-cap quality compounder stock; SIGA is a small-cap deep-value stock; XTLB is a small-cap quality compounder stock. NXRT, SIGA pay a dividend while BHST, GFAI, XTLB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BHST

High-Growth Disruptor

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 19%
  • Gross Margin > 35%
Run This Screen
Stocks Like

NXRT

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 54%
  • Dividend Yield > 2.8%
Run This Screen
Stocks Like

GFAI

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
Run This Screen
Stocks Like

SIGA

Dividend Mega-Cap Quality

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 14%
  • Dividend Yield > 5.1%
Run This Screen
Stocks Like

XTLB

Quality Business

  • Sector: Healthcare
  • Market Cap > $20B
  • Gross Margin > 15%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BHST and NXRT and GFAI and SIGA and XTLB on the metrics below

Revenue Growth>
%
(BHST: 38.7% · NXRT: 0.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.